Market Introduction
Major countries included as a part of analysis for SAM includes Argentina, Brazil, and the rest of SAM. Brazil dominated the market in 2021. Brazil is the fifth largest country globally, both by area and demand for animal meat food. The various companies and organizations operate in the business related to livestock. For instance, as per the report Livestock and Products Annual by the US Department of Agriculture, Foreign Agricultural Service August 2020, the production of beef is expected to rise by 4% in 2021, which is accounted for about 10.5 million metric tons. And similarly, the other types of pork are also likely to increase in exports, and domestic demand for meat products is expected to lead the related markets in the forecast period. Moreover, as per the Brazilian-American Chamber of Commerce, Brazil supplies about 22% of poultry imports of Saudi Arabia in October 2020. The presence of livestock and poultry other associated businesses in the country is expected to generate steady demand for animal health products such as vaccines, medications, and feed supplements. Growing market in untapped economies and awareness of diagnosis and increasing incidence of zoonotic diseases are the major factor driving the growth of the SAM veterinary vaccines market. However, strict government rules related to usage of veterinary vaccines hinders the growth of SAM veterinary vaccines market.
In case of COVID-19, SAM is highly affected especially Brazil. The outbreak of COVID–19 has stringently affected medical services in the SAM region. Also, the nations are famous for medical tourism, which is also influenced by the pandemic. The infection is being transferred from an infected human to an animal. Thus, creating a concern about the spread of COVID19 among the animals is not yet reported. There is a strong possibility of infection of animals in the region in the region. Various investigation studies have been performed to check the disease of COVID19 among the animals. For instance, the National Library of Medicine, in April 2021, published a study ‘Investigation of SARS-CoV-2 condition in dogs and cats of humans diagnosed with COVID-19 in Rio de Janeiro, Brazil.’ The study concluded that the presence and persistence of SARS-CoV-2 disease had been identified in dogs and cats from households with human COVID-19 cases in the locations such as Rio de Janeiro, Brazil. The recommends people with COVID-19 should avoid close contact with their pets during the time of their illness. Thus, the pandemic is expected to impact the animal health-related markets in the region.
Market Overview and Dynamics
The SAM veterinary vaccines market is expected to grow from US$ 671.54 million in 2021 to US$ 997.88 million by 2028; it is estimated to grow at a CAGR of 5.8% from 2021 to 2028. According to WHO, foodborne disease (FBD) is one of the primary causes of morbidity and mortality. The diseases can be developed by several chemical pollutants, bacteria, viruses, parasites, and biotoxins and are generally referred to as neglected diseases. The spread of FBD and its repercussions are major concerns to human health. The expanding human population and changing diet trends (more protein in meals) are expected to boost the consumption of animal products to 376 million tons by 2030. The growing demand for animal products, coupled with increasing awareness about animal welfare, leads to changes in operational management. Like humans, pets and farm animals are susceptible to many diseases caused by bacteria, viruses, fungus, and parasites. Therefore, several techniques, such as veterinary vaccination, have been employed. The vaccines are licensed and manufactured under tight regulatory circumstances to ensure their safety, effectiveness, and quality. Veterinary vaccines against foodborne parasites improve animal health by reducing animal infections and help improve public health by managing an essential source of FBDs. In addition, vaccines safeguard farm animals by preventing or reducing the danger of certain infectious diseases. Healthy animals are the cornerstone of healthy eating; hence, immunizations help safeguard animal-made foods. The veterinary profession provides farmers with the immunizations needed to protect their animals' health and welfare. In animal husbandry, using antibiotics only when essential to protect animal health, means depending on non-antibiotic alternatives to control animal health, and making optimal treatment decisions regarding the antibiotic selection and treatment procedure when antibiotics are required. Vaccines are a possible alternative to intensive antibiotics. In a recent cross-border expert rating of alternatives to antimicrobial drugs in pig production, vaccinations were ranked in terms of perceived feasibility and among the top five alternative techniques in terms of perceived efficacy. So, rising prevalence of foodborne diseases and infections is expected to fuel the SAM market growth.
Key Market Segments
In terms of vaccine type, the livestock vaccines segment accounted for the largest share of the SAM veterinary vaccines market in 2020. In terms of technology, the live attenuated vaccines segment held a larger market share of the SAM veterinary vaccines market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the SAM veterinary vaccines market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Boehringer Ingelheim International GmbH; Ceva; Elanco; HIPRA; Merck & Co., Inc.; NEOGEN Corporation; Virbac; and Zoetis Inc. among others.
Reasons to buy report
SAM Veterinary Vaccines Market Segmentation
SAM Veterinary Vaccines Market - By Vaccine Type
SAM Veterinary Vaccines Market - By Technology
SAM Veterinary Vaccines Market - By Country
SAM Veterinary Vaccines Market - Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 671.54 Million |
| Market Size by 2028 | US$ 997.88 Million |
| CAGR (2021 - 2028) | 5.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Vaccine Type
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South America Veterinary Vaccines Market is valued at US$ 671.54 Million in 2021, it is projected to reach US$ 997.88 Million by 2028.
As per our report South America Veterinary Vaccines Market, the market size is valued at US$ 671.54 Million in 2021, projecting it to reach US$ 997.88 Million by 2028. This translates to a CAGR of approximately 5.8% during the forecast period.
The South America Veterinary Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Veterinary Vaccines Market report:
The South America Veterinary Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South America Veterinary Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South America Veterinary Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South America Veterinary Vaccines Market
